The cannabis industry as a whole has remained incredibly successful over the course of the past several months, but new updates to legislation and the changing public perception of cannabis have all contributed to the markets further success. Several stocks due to this have moved to the forefront of the industry, and continue to lead the market in ways no one ever thought possible.
The company Tilray (NASDAQ:TLRY) has been one of the key players in the industry for some time now. Tilray has been working to begin massive about of production to help meet the new and growing demands of the legal cannabis space in Canada. With legal recreational cannabis hitting the Canadian market as soon as October 17th, it seems as though Tilray is poised perfectly to take advantage of this space. Tilray has reported their sales to be around $20 million which puts them in the higher grade of sales reports for the cannabis industry. According to one report “Tilray should have plenty of capacity to meet the demand for recreational marijuana in its home country when the market opens in October. The company is expanding its facilities and expects to have 912,000 square feet of growing space by the end of this year, with 682,000 square feet of that space in Canada and the rest at its Portugal facility.” These new domestic and abroad facilities should help Tilray to meet this high demand for the future of the industry. Tilray has also been working to line up agreements all over the Canadian space such as in British Columbia and Quebec. The company in addition, has been working to make their sales go right to the consumer rather than having to work through a middle man of sorts. Because of this, Tilray should be kept on any investors watch list.
The next company on the list and one that should come as no surprise is the Cronos Group (NASDAQ:CRON). The company is another one of the key Canadian players in the market and has been working to up their supply to meet the demands of the global medical cannabis market as well as the domestic recreational industry. The company has also recently posted a 234% year over year growth from one of their brands known as Peace Naturals. According to one report “Cronos’ prospects in Canada’s recreational marijuana market are much better. Some project that total recreational cannabis sales in the first year will top CA$5 billion. To become a major player in this market, companies must have ample production capacity and a solid distribution channel for the retail market. Cronos should have all of these bases covered.” If Cronos is able to line up this work perfectly, they can expect to be one of the top players in the market even more so than they are now.
Lastly, the company Marapharm Ventures ( MRPHF ) has been working to move to the top of the cannabis space. As a public company which invests in health and wellness, including medical and recreational marijuana.” Companies like this have been quickly moving to the front of the market as the demand continues to increase into the future.
The hopes are high that over the course the next few months to years, the cannabis space will continue to grow with a massive amount of propensity toward the future as it has done thus far.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Marapharm Ventures, Midam has been paid $200,000 from the company and ZERO shares of Marapharm Ventures Inc. for a duration beginning June 27, 2018 and ending July 27, 2018. We may buy or sell additional shares of (MRPHF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
